Advanced Therapies Journal

Advanced Therapies Journal

Systematic Review: The Effect of Brachytherapy in Prostate Cancer

Document Type : Original Article

Authors
Nahid Eghbalpour 1
Kamran Eghbalpour 2
Asal Ahmadi 3
1 Department of biology, Shahre-e-Qods branch, Islamic Azad University, Tehran, Iran
2 Department of biology, Shahre-e-Qods branch, Islamic Azad University, Tehran, Iran.
3 Department of biology, Alborz Branch, Islamic Azad University, Karaj, Iran.
10.22034/atj.2025.528922.1015
Abstract
One of the most often occurring cancers among men globally, prostate cancer (PCa) is on rise. External beam radiation therapy (EBRT), brachytherapy, and radical prostatectomy are three treatments now used for localized prostate cancer. Direct implmentation of radioactive seeds into the prostate for brachytherapy is one less intrusive alternative to other, more forceful treatment approaches.
The present work reviews the body of knowledge on brachytherapy for prostate cancer and investigates how treatment influences oncological outcomes, possible side effects, and quality of life of patients. This paper looks at various studies to see how effective brachytherapy is compared to other treatment options. Brachytherapy is just as successful as other techniques in lowering the risk of disease recurrence since it has fewer side effects and patients recover faster. The effects on lifespan and well-being are yet unknown for researchers. An overview of brachytherapy as a known therapeutic option is given in this paper, together with the need for tailored treatment strategies depending on patient risk factors.
Keywords
Prostate cancer
Brachytherapy
Radiation therapy
Cancer management
1.    Jain MA, Leslie SW, Sapra A. Prostate Cancer Screening.  StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Stephen Leslie declares no relevant financial relationships with ineligible companies. Disclosure: Amit Sapra declares no relevant financial relationships with ineligible companies.: StatPearls Publishing
Copyright © 2025, StatPearls Publishing LLC.; 2025.
2.    Rawla P. Epidemiology of Prostate Cancer. World journal of oncology. 2019;10(2):63-89.
3.    James ND, Tannock I, N’Dow J, Feng F, Gillessen S, Ali SA, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. The Lancet. 2024;403(10437):1683-722.
4.    Williams IS, McVey A, Perera S, O’Brien JS, Kostos L, Chen K, et al. Modern paradigms for prostate cancer detection and management. The Medical journal of Australia. 2022;217(8):424-33.
5.    Zhang P, Qian B, Shi J, Xiao YJTA, Urology. Radical prostatectomy versus brachytherapy for clinically localized prostate cancer on oncological and functional outcomes: a meta-analysis. 2020. 2020;9(2):332-43.
6.    Novirianthy R, Syukri M, Gondhowiardjo S, Suhanda R, Mawapury M, Pranata A, et al. Treatment acceptance and its associated determinants in cancer patients: A systematic review. Narra J. 2023;3(3):e197.
7.    Mendez LC, Morton GCJTA, Urology. High dose-rate brachytherapy in the treatment of prostate cancer. 2018. 2018;7(3):357-70.
8.    Palled SR, Saminathan S, Pasha T, Naveen T, Ganesh KM, Lokesh V. Prostate permanent implant brachytherapy with BARC I-125 Ocu-Prosta seeds. Journal of Cancer Research and Therapeutics. 2021;17(2).
9.    Goy BW, Burchette R, Soper MS, Chang T, Cosmatos HA. Ten-Year Treatment Outcomes of Radical Prostatectomy Vs External Beam Radiation Therapy Vs Brachytherapy for 1503 Patients With Intermediate-risk Prostate Cancer. Urology. 2020;136:180-9.
10.Fonseca GP, Johansen JG, Smith RL, Beaulieu L, Beddar S, Kertzscher G, et al. In vivo dosimetry in brachytherapy: Requirements and future directions for research, development, and clinical practice. Physics and Imaging in Radiation Oncology. 2020;16:1-11.
11.Nugent K, Das P, Ford D, Sabharwal A, Perna C, Dallas N, et al. Stereotactic Magnetic Resonance–Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity Outcomes. Advances in Radiation Oncology. 2024;9(9):101574.
12.D’Hulst P, Mattelaer P, Darras J, Staelens L, Pottel H, Ponette D. Low-dose-rate brachytherapy as a minimally invasive curative treatment for localised prostate cancer has excellent oncological and functional outcomes: a retrospective analysis from a single centre. Central European journal of urology. 2018;71(3):270-5.
13.Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet. 2024;404(10459):1199-226.
 

  • Receive Date 30 April 2025
  • Revise Date 23 May 2025
  • Accept Date 29 May 2025